HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Weiyan Cheng Selected Research

Proteolysis Targeting Chimera

11/2021Development of hypoxia-activated PROTAC exerting a more potent effect in tumor hypoxia than in normoxia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Weiyan Cheng Research Topics

Disease

5Neoplasms (Cancer)
11/2021 - 01/2014
4Hypoxia (Hypoxemia)
11/2021 - 12/2014
2Infections
01/2021 - 11/2019
1Inflammation (Inflammations)
01/2019
1Esophageal Squamous Cell Carcinoma
01/2019

Drug/Important Bio-Agent (IBA)

3Phosphotransferases (Kinase)IBA
01/2019 - 01/2014
3Biological ProductsIBA
01/2019 - 01/2015
2Pharmaceutical PreparationsIBA
11/2019 - 01/2019
2QuinazolinesIBA
01/2019 - 01/2015
2NitroimidazolesIBA
01/2019 - 01/2015
2Gefitinib (Iressa)FDA Link
01/2015 - 12/2014
1ErbB Receptors (EGF Receptor)IBA
11/2021
1snake venom protein C activatorIBA
11/2021
1Proteolysis Targeting ChimeraIBA
11/2021
1ProdrugsIBA
11/2021
1Proteins (Proteins, Gene)FDA Link
11/2021
1Carbapenems (Carbapenem Antibiotics)IBA
01/2021
1L 084IBA
01/2021
1Anti-Bacterial Agents (Antibiotics)IBA
01/2021
1Small Interfering RNA (siRNA)IBA
01/2019
1aniline (aniline hydrobromide)IBA
01/2019
1oridoninIBA
01/2019
1Cyclin-Dependent Kinases (cdk Proteins)IBA
01/2019
1Lapatinib (GW572016)FDA Link
01/2019
1anilinoquinazolineIBA
12/2014
1Erlotinib Hydrochloride (CP 358,774)FDA Link
12/2014

Therapy/Procedure

3Therapeutics
01/2019 - 01/2014
1Chinese Traditional Medicine (Traditional Chinese Medicine)
01/2019